Assault on vaccines is a call to arms for Rx
Now changes in federal policy are beginning to have a direct impact on what goes on in the pharmacy.
Opinion
Elayne Kwait: Always anticipated, never forgotten
David Pinto looks at the laudatory life of Elayne Kwait, who passed away after a long illness last month. He recalls her role in helping put an indelible stamp on chain drug retailing in the 20th century.
Cencora brings cohesion to its customers
“Strategic partnerships are the ethos of what we want to do,” Rich Tremonte explains.
Four chain drug industry assets that refute its critics
David Pinto details four of the many major assets that accompany the chain drug store into the second quarter of the 21st century in the United States.
It’s time to contemplate alternatives to PBM reform
By Todd Huseby, partner and head of the health care practice at Kearney.
Make the most of the reinvented search experience
By Jill Standish, Accenture’s global retail lead
Use AI to make shopping easier, not as a shortcut
By Andrea Leigh, founder and chief executive officer of the Allume Group
Technology is humanizing pharma ad campaigns
By Emily Keith, senior vice president of Cadent Health
How to understand and manage category disruption
By Brian Owens, managing director of strategy and insights at BAV Group
Brick-and-mortar retailing is far from its death bed
By Dave Wendland, vice president of strategic relations and member of the HRG owner group